𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections

✍ Scribed by Prabhat C. Maudgal; Erik De Clercq; Luc Missotten

Book ID
118391736
Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
531 KB
Volume
4
Category
Article
ISSN
0166-3542

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antibodies against varicella-zoster viru
Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections
✍ C. F. R. KΓ€llander; E. G. Torfason; H. Diderholm; J. S. Gronowitz; E. Olding-Ste πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 707 KB

Antibody responses to varicella-zoster virus (VZV) deoxythymidine kinase (dTK) and herpes simplex virus (HSV) dTK in homologous and heterologous infections were studied. Antibodies blocking the enzymatic activity of VZV-dTK appeared late after varicella and decreased more or less in parallel with th

Oral bromovinyldeoxyuridine therapy for
Oral bromovinyldeoxyuridine therapy for herpes simplex and varicella-zoster virus infections in severely immunosuppressed patients: A preliminary clinical trial
✍ G. Tricot; Prof. E. De Clercq; M. A. Boogaerts; R. L. Verwilghen πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 556 KB

Twenty-five patients with haematological diseases were treated orally with the highly potent and selective anti-herpes agent, bromovinyldeoxyuridine (BVDU), in a dosage of 7.5 mglkglday (divided over three or four doses a day) for 5 days for an intercurrent mucocutaneous herpesvirus infection. Of th